T-cell acute lymphoblastic leukemia |
Jurkat, MOLT-4 |
Up |
CYLD |
NF-Kappa B signaling pathway |
hsa-miR-19 regulates the expression of CYLD and controls NF-Kappa B expression in downstream signaling pathway in T-cell acute lymphoblastic leukemia. |
Ye et al., 2012 |
Hepatitis C virus infection |
Huh-7.5.1 |
Up |
|
PI3K-Akt signaling pathway |
MicroRNA-199a promotes HCV replication by regulating PI3K-Akt signaling pathway. |
Wang et al., 2015 |
Hepatitis C virus infection |
Huh-7.5.1 |
Up |
|
RAS signaling pathway |
MicroRNA-199a promotes HCV replication by regulating Ras/ERK pathway. |
Wang et al., 2015 |
Hepatitis C virus infection |
Huh-7.5.1 |
Up |
|
Wnt signaling pathway |
MicroRNA-199a promotes HCV replication by regulating Wnt signaling pathway. |
Wang et al., 2015 |
Gastric cancer |
MKN28, AGS |
|
MEF2D |
Wnt signaling pathway |
MicroRNA-19 inhibits Wnt signaling pathway through targeting MEF2D in gastric cancer. |
Xu et al., 2016 |
Gastric cancer |
Stomach |
Up |
|
PI3K-Akt signaling pathway |
Upregulation of miR-19a induces the epithelial-mesenchymal transition through activating the PI3K-Akt signaling pathway. |
Lu et al., 2015 |
Gastric cancer |
SGC-7901, NUGC-3 |
Up |
|
PI3K-Akt signaling pathway |
Upregulation of miR-19a increases the epithelial-mesenchymal transition via activating PI3K-Akt signaling pathway. |
Lu et al., 2014 |
Gastric cancer |
GC9811, GC9811-P, MKN28, GES-1 |
Up |
E CADHERIN |
Cadherin signaling pathway |
Suppression of miR-199a impairs the metastatic potential of gastric cancer cells. Upregulation of miR-199a-5p inhibits the expression of E-cadherin. |
Zhao et al., 2014 |
Gastric cancer |
Stomach |
Down |
MTOR |
mTOR pathway |
Overexpression of miRNA-199a inhibits cancer cell proliferation through targeting the mTOR signaling pathway. |
Peng et al., 2014 |
Gastric cancer |
SNU-16 |
Up |
SMAD4 |
TGF-beta signaling pathway |
Upregulation of miR-199a suppresses the ability of TGF-beta to induce gastric cancer cell growth arrest and apoptosis through targeting Smad4. |
Zhang et al., 2012 |
Non-alcoholic fatty liver disease |
Hep-G2 |
Up |
CAV1 |
PPAR signaling pathway |
Overexpression of miR199a in hepatocytes is associated with impaired FA beta-oxidation in mitochondria and aberrant lipid deposits through the PPAR signaling pathway. |
Li et al., 2014 |
Non-small cell lung cancer |
Lung |
Down |
HNUDC |
ERK pathway |
Over-expression of miR-194 suppresses the expression of Mpl/ERK pathway proteins, and inhibits the mitosis and proliferation of non-small cell lung cancer cells. |
Zhou et al., 2016 |
Lung cancer |
HBE |
Up |
BASP1 |
Wnt signaling pathway |
MicroRNA-191 regulates the epithelial-mesenchymal transition and the cancer stem cell-like properties of transformed cells. |
Xu et al., 2015 |
Breast cancer |
MCF-7, MCF-10A, MDA-MB-468, HCT 116, PANC-1 |
|
BRCA2 |
Homologous recombination DNA repair pathway |
Upregulation of hsa-miR-19a is associated with reduced expression of BRCA2 in breast cancer. |
Mogilyansky et al., 2016 |
Breast cancer |
MCF-7, MCF-10A, MDA-MB-468, HCT 116, PANC-1 |
|
BRCA2 |
Homologous recombination DNA repair pathway |
MicroRNA-19b directly inhibits the expression of BRCA2 in breast cancer. |
Mogilyansky et al., 2016 |
Breast cancer |
Breast |
Down |
PAK4 |
ERK pathway |
MicroRNA-199a inhibits migration and invasion of breast cancer cells by inactivating PAK4/MEK/ERK signaling pathway. |
Li et al., 2015 |
Breast cancer |
Breast |
Down |
PAK4 |
ERK pathway |
MicroRNA-199b inhibits migration and invasion of breast cancer cells by inactivating PAK4/MEK/ERK signaling pathway. |
Li et al., 2015 |
Hepatocellular carcinoma |
HEK293T, Huh-7 |
Down |
SLC39A6 |
SNAIL pathway |
MicroRNA-192 inhibits the SNAIL pathway to reduce tumor metastasis in hepatocellular carcinoma cells. |
Lian et al., 2016 |
Glioblastoma |
SW1783, SW1088, SNB-19 |
Up |
PTEN |
PTEN pathway |
Overexpression of hsa-miR-1908 inhibits the expression of PTEN. miR-1908 acts as oncogene through repressing PTEN pathway. |
Xia et al., 2015 |
Hepatocellular carcinoma |
Hepatocyte |
Down |
TRIM23 |
NF-Kappa B signaling pathway |
hsa-miR-23 directly targeted TRIM23. TNF alpha-NF-Kappa B signaling switches off negative regulation by repressing HNF-1 alpha-mediated expression of hsa-miR-194. |
Bao et al., 2015 |
Hepatocellular carcinoma |
Hepatocyte |
Down |
MCL1 |
Caspase 3 pathway |
Mcl-1 is the direct target of hsa-miR-193b and overexpression of hsa-miR-193b increased cancer cell sensitivity via caspase dependent apoptosis pathway. |
Yin et al., 2015 |
Cervical cancer |
HaCaT |
Down |
SMAD3 |
miR-195/Smad3 pathway |
MicroRNA-195 inhibits migration and invasion of cervical cancer by targeting Smad3 expression. |
Zhou et al., 2016 |
Cervical cancer |
HeLa, SiHa |
Down |
CYCLIN D1 |
CDK pathway |
MiR-195 suppresses human cervical cancer cells proliferation by directly inhibiting cyclin D1 expression. |
Li et al., 2016 |
Cervical cancer |
HeLa, Ca Ski, SiHa |
Up |
FOXO1 |
PI3K-Akt signaling pathway |
MicroRNA-196a enhances cervical cancer proliferation through targeting FOXO1, the key effector of the PI3K/Akt signaling pathway. |
Hou et al., 2014 |
Cervical cancer |
HeLa, Ca Ski, SiHa |
Up |
P27KIP1 |
PI3K-Akt signaling pathway |
MicroRNA-196a enhances cervical cancer proliferation through targeting p27Kip1, the key effector of the PI3K/Akt signaling pathway. |
Hou et al., 2014 |
Ovarian cancer |
Ovary |
Up |
NLK |
Wnt signaling pathway |
MicroRNA-197 promotes Taxol resistance in human ovarian cancer cells by down-regulating NLK expression. |
Zou et al., 2015 |
Bladder cancer |
5637 |
|
HOXC9 |
Oxidative stress pathway |
MicroRNA-193a enhances the multi-chemoresistance of bladder cancer by down-regulating the HOXC9 expression. |
Lv et al., 2015 |
Bladder cancer |
UM-UC-3, T24, 5637 |
Up |
LOXL4 |
Oxidative stress pathway |
MicroRNA-193a induces the multi-chemoresistance of bladder cancer cells by down-regulating lysyl oxidase-like 4 (LOXL4) expression. |
Deng et al., 2014 |
Laryngeal squamous cell carcinoma |
HEp-2 |
Up |
TIMP2 |
TIMP-2 pathway |
MicroRNA-19a functions as an oncogene in the progression of laryngeal squamous cell carcinoma by targeting TIMP-2 expression. |
Wu etal., 2013 |
Oral squamous cell carcinoma |
SCC-9, SCC-25, |
Down |
AGK |
PI3K-Akt signaling pathway |
MicroRNA-194 acts as a potential tumor suppressor by targeting the PI3K-Akt signaling pathway. |
Chi et al., 2015 |
Pulmonary arterial hypertension |
Lung |
Up |
GSK 3 BETA |
Wnt signaling pathway |
Overexpression of miR-199b in hypoxic pulmonary arterial epithelial cells downregulates GSK3B expression. |
Wu et al., 2016 |
Asthma |
Bronchial epithelial cell |
Up |
TGFBR2 |
TGF-beta signaling pathway |
hsa-miR-19a increased bronchial epithelial cell proliferation in severe asthma through inhibiting TGF-beta receptor 2 mRNA level. |
Haj-salem et al., 2015 |